Products for Topic: Targeted Therapy
Calicheamicin
Ceritinib
Ruxolitinib Phosphate
Sunitinib Malate
Brigatinib
Olaparib
GSK-1120212
Lapatinib Ditosylate
SBE 13 hydrochloride
GSK2636771
Ponatinib
Lenvatinib Intermediate
![4(3H)-Quinazolinone, 5-fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]](https://www.nbinno.com/webimg/gemini_688eb249525db_1754182217.png)
4(3H)-Quinazolinone, 5-fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]
Binimetinib
Ibrutinib
MEK Inhibitor
Bortezomib API
AZD-9291
Sorafenib Tosylate
Tucatinib
Lapatinib Ditosylate
![6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]pheny](https://www.nbinno.com/webimg/gemini_688ad45675e05_1753928790.png)
6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]pheny
Dual PI3K/mTOR Inhibitor
